SEC Form 4Coverage since May 26, 2026
$KRYS insider trading
Over the last 12 months, Krystal Biotech insiders reported no purchases and 24 sales totaling $15.9M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $15.9M 24 events
- Events · 12m
- 24 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $KRYS · 12Mvia TradingView
Top insiders · 12m
Krishnan SumaPresident, R&D11× · $7.7M
Krishnan Krish SPresident and CEO11× · $7.7M
Thomas John CharlesEVP, General Counsel2× · $541K
All insider trades
24 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Thomas John CharlesEVP, General Counsel · O | ▼ Sale | 1,000 | $347.27 | $347K | -100% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 240 | $311.65 | $75K | — | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 2,039 | $310.94 | $634K | -0.1% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 2,801 | $309.95 | $868K | -0.2% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 3,803 | $308.89 | $1.2M | -0.3% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 12,729 | $307.81 | $3.9M | -0.9% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 1,348 | $307.09 | $414K | -0.1% | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 480 | $305.86 | $147K | — | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 400 | $304.89 | $122K | — | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 247 | $303.17 | $75K | — | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 593 | $302.25 | $179K | — | plan |
| Jun 4, 2026 | Krishnan SumaPresident, R&D · O·D·10% | ▼ Sale | 320 | $300.75 | $96K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 40 | $312.23 | $12K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 964 | $311.36 | $300K | -0.1% | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 2,652 | $310.43 | $823K | -0.2% | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 2,784 | $309.49 | $862K | -0.2% | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 4,830 | $308.47 | $1.5M | -0.3% | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 11,461 | $307.68 | $3.5M | -0.8% | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 589 | $306.33 | $180K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 544 | $304.81 | $166K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 176 | $303.17 | $53K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 640 | $302.24 | $193K | — | plan |
| Jun 4, 2026 | Krishnan Krish SPresident and CEO · O·D·10% | ▼ Sale | 320 | $300.75 | $96K | — | plan |
| May 26, 2026 | Thomas John CharlesEVP, General Counsel · O | ▼ Sale | 642 | $302.03 | $194K | -100% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $KRYS feed.